Terms: = Liver cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM
151 results:
1. Risk of HBV reactivation in HCC patients undergoing combination therapy of PD-1 inhibitors and angiogenesis inhibitors in the antiviral era.
Wang R; Tan G; Lei D; Li Y; Gong J; Tang Y; Pang H; Luo H; Qin B
J Cancer Res Clin Oncol; 2024 Mar; 150(3):158. PubMed ID: 38530426
[TBL] [Abstract] [Full Text] [Related]
2. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
3. Anatomical thermal ablation as an alternative to surgical resection for subcapsular hepatocellular carcinoma.
Long Y; Zeng Q; He X; Wu Y; Ye H; Xu J; Chen J; Yuan L; Li H; Li K
Abdom Radiol (NY); 2024 Apr; 49(4):1144-1153. PubMed ID: 38289353
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.
Kut E; Menekse S
Sci Rep; 2024 Jan; 14(1):1371. PubMed ID: 38228667
[TBL] [Abstract] [Full Text] [Related]
5. Clinical application value of hepatitis B virus basal core promoter 1762/1764 and GGTII and GGT in patients with HBV-DNA-positive primary liver cancer.
Qiu S; Jin L; Yang D; Zhang D
Medicine (Baltimore); 2023 Oct; 102(43):e35699. PubMed ID: 37904480
[TBL] [Abstract] [Full Text] [Related]
6. Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors.
Li N; Dong T; Wang P; Li Q; Nie F
Clin Hemorheol Microcirc; 2023; 85(4):407-420. PubMed ID: 37638421
[TBL] [Abstract] [Full Text] [Related]
7. Long-term efficacy and safety of microwave ablation for hepatocellular carcinoma adjacent to the gallbladder with a diameter ≤ 5 cm: a multicenter, propensity score matching study.
Li L; Yao J; Yan X; Qi X; Liang P; Han Z; Liu F; Cheng Z; Luo Y; Zheng R; Cheng W; Wei Q; Yu S; Yu J; Yu X
Int J Hyperthermia; 2023; 40(1):2248425. PubMed ID: 37607775
[TBL] [Abstract] [Full Text] [Related]
8. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract] [Full Text] [Related]
9. The interaction between microbiota and immune in intestinal inflammatory diseases: Global research status and trends.
Liu C; Su W; Tan Z; Zhang J; Dong W
Front Cell Infect Microbiol; 2023; 13():1128249. PubMed ID: 36824689
[TBL] [Abstract] [Full Text] [Related]
10. Trends in Survival and Surgical Methods in Patients Surgically Treated for Metastatic Spinal Tumors: 25-Year Experience in a Single Institution.
Park SJ; Park JS; Lee CS; Kang BJ; Jung CW
Clin Orthop Surg; 2023 Feb; 15(1):109-117. PubMed ID: 36778984
[TBL] [Abstract] [Full Text] [Related]
11. Peripheral immune factors aiding clinical parameter for better early recurrence prediction of hepatocellular carcinoma after thermal ablation.
Fan F; Dong G; Han C; Ding W; Li X; Dong X; Wang Z; Liang P; Yu J
Int J Hyperthermia; 2023; 40(1):2172219. PubMed ID: 36775652
[TBL] [Abstract] [Full Text] [Related]
12. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
Na YS; Kim SG; Cho SJ
Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
[TBL] [Abstract] [Full Text] [Related]
13. The development of a cSMART-based integrated model for hepatocellular carcinoma diagnosis.
Wu T; Fan R; Bai J; Yang Z; Qian YS; Du LT; Wang CY; Wang YC; Jiang GQ; Zheng D; Fan XT; Zheng B; Liu JF; Deng GH; Shen F; Hu HP; Ye YN; Zhang QZ; Zhang J; Gao YH; Xia J; Yan HD; Liang MF; Yu YL; Sun FM; Gao YJ; Sun J; Zhong CX; Wang Y; Wang H; Kong F; Chen JM; Wen H; Wu BM; Wang CX; Wu L; Hou JL; Liu XL; Wang HY; Chen L
J Hematol Oncol; 2023 Jan; 16(1):1. PubMed ID: 36600307
[TBL] [Abstract] [Full Text] [Related]
14. Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma.
Atieh T; Atrash S; Ahmed N; Mohan M; Cui W; Shune L; Hajjar S; Mahmoudjafari Z; Quick J; Wishna A; Riffel J; McGuirk J; Mohyuddin GR; Abdallah AO
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):912-919. PubMed ID: 36127271
[TBL] [Abstract] [Full Text] [Related]
15. Factors affecting prognosis in hepatocellular carcinoma patients post-transarterial chemoembolization.
Prateepchaiboon T; Chang A; Pungpipattrakul N; Akarapatima K; Rattanasupar A; Songjamrat A; Pakdeejit S; Piratvisuth T
Indian J Gastroenterol; 2022 Aug; 41(4):352-361. PubMed ID: 36029371
[TBL] [Abstract] [Full Text] [Related]
16. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.
Dum D; Ocokoljic A; Lennartz M; Hube-Magg C; Reiswich V; Höflmayer D; Jacobsen F; Bernreuther C; Lebok P; Sauter G; Luebke AM; Burandt E; Marx AH; Simon R; Clauditz TS; Minner S; Menz A; Büscheck F; Gorbokon N; Steurer S; Blessin NC; Krech T
Virchows Arch; 2022 Dec; 481(6):945-961. PubMed ID: 35951102
[TBL] [Abstract] [Full Text] [Related]
17. Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial.
Zheng DH; Yang JM; Wu JX; Cheng SQ; Zhang SG; Wu D; Li AJ; Fu XH; Li X; Qi FC; Duan WH; Chen JH; Yang ZY; Liang L; Zeng JX; Zheng WD; Wu MC
Chin J Integr Med; 2023 Jan; 29(1):3-9. PubMed ID: 35915317
[TBL] [Abstract] [Full Text] [Related]
18. CT-based skeletal muscle loss for predicting poor survival in patients with hepatocellular carcinoma experiencing curative hepatectomy plus adjuvant transarterial chemoembolization: a preliminary retrospective study.
Yang S; Zhang Z; Su T; Yu J; Cao S; Wang H; Jin L
Eur J Med Res; 2022 Jul; 27(1):131. PubMed ID: 35879734
[TBL] [Abstract] [Full Text] [Related]
19. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
[TBL] [Abstract] [Full Text] [Related]
20. Weight-change trajectory in relation to cancer risk: findings from a nationwide cohort study in South Korea.
Tran TPT; Luu NM; Bui TT; Han M; Lim MK; Oh JK
Obesity (Silver Spring); 2022 Jul; 30(7):1507-1519. PubMed ID: 35785482
[TBL] [Abstract] [Full Text] [Related]
[Next]
